UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$463M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$360M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$345M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$265M |
| 5 |
ConocoPhillips
COP
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$293M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$239M |
| 5 |
UnitedHealth
UNH
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLO
2201
DELISTED
Olo Inc
OLO
| $619K | ﹤0.01% |
78,311
| – | – |
|
2202
Mercer International
MERC
$39.8M
| $618K | ﹤0.01% |
50,254
+8,906
| +22% | +$132K |
|
|
NFBK
2203
DELISTED
Northfield Bancorp
NFBK
| $617K | ﹤0.01% |
43,091
+7,659
| +22% | +$111K |
|
2204
Blink Charging
BLNK
$87.9M
| $616K | ﹤0.01% |
34,743
+333
| +1% | +$6.83K |
|
2205
Alphatec Holdings
ATEC
$1.44B
| $613K | ﹤0.01% |
70,113
-8,274
| -11% | -$65.4K |
|
2206
International Money Express
IMXI
$367M
| $612K | ﹤0.01% |
26,834
-3,681
| -12% | -$86.5K |
|
2207
Kodiak Sciences
KOD
$2.84B
| $606K | ﹤0.01% |
78,298
+24,635
| +46% | +$239K |
|
|
GOLD
2208
Gold.com Inc
GOLD
$1.26B
| $604K | ﹤0.01% |
21,264
+1,522
| +8% | +$46.3K |
|
2209
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| – | – |
0
| – | – |
|
2210
Byline Bancorp
BY
$1.76B
| $601K | ﹤0.01% |
29,658
+5,229
| +21% | +$120K |
|
|
GLDD
2211
DELISTED
Great Lakes Dredge & Dock
GLDD
| $600K | ﹤0.01% |
79,219
| – | – |
|
|
OSG
2212
Octave Specialty Group
OSG
$222M
| $599K | ﹤0.01% |
47,005
-9,418
| -17% | -$125K |
|
|
MRSN
2213
DELISTED
Mersana Therapeutics
MRSN
| $597K | ﹤0.01% |
3,535
| – | – |
|
2214
GeoPark
GPRK
$612M
| $597K | ﹤0.01% |
50,915
+3,700
| +8% | +$45.5K |
|
2215
Mercury Insurance
MCY
$6.07B
| $595K | ﹤0.01% |
20,949
-6,726
| -24% | -$244K |
|
2216
Vanda Pharmaceuticals
VNDA
$302M
| $594K | ﹤0.01% |
60,150
| – | – |
|
|
PYCR
2217
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $593K | ﹤0.01% |
20,074
+699
| +4% | +$20.2K |
|
2218
Hims & Hers Health
HIMS
$7.31B
| $591K | ﹤0.01% |
105,998
-29,108
| -22% | -$175K |
|
2219
Central Garden & Pet Co
CENT
$2.8B
| $591K | ﹤0.01% |
20,499
-1,571
| -7% | -$52.4K |
|
2220
iShares MSCI Poland ETF
EPOL
$818M
| $591K | ﹤0.01% |
54,868
| – | – |
|
2221
World Acceptance Corp
WRLD
$873M
| $590K | ﹤0.01% |
6,094
-434
| -7% | -$50.3K |
|
2222
GoPro
GPRO
$126M
| $589K | ﹤0.01% |
119,385
-5,480
| -4% | -$32.6K |
|
|
TRST
2223
Trustco Bank Corp NY
TRST
$938M
| $588K | ﹤0.01% |
18,710
-3,099
| -14% | -$103K |
|
2224
AnaptysBio
ANAB
$1.68B
| $587K | ﹤0.01% |
23,007
+8,361
| +57% | +$196K |
|
2225
Clover Health Investments
CLOV
$2.51B
| $586K | ﹤0.01% |
344,953
+100,391
| +41% | +$263K |
|
Similar funds
UBS AM's Q3 2022 Portfolio in Review
As of Q3 2022, UBS AM held 2,816 positions worth $178B, down 6.6% from $191B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q3 2022 filing shows 65 new, 702 increased, 1,679 reduced and 77 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M. The largest sale was Apple, an estimated $2.03B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q3 2022 buy was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M.
- UBS AM added most to Accenture in Q3 2022, an estimated $463M increase.
- UBS AM's biggest Q3 2022 reduction was Apple, cutting an estimated $2.03B.
- UBS AM fully exited Vanguard Russell 1000 ETF in Q3 2022, selling an estimated $93.3M.
- UBS AM's ten largest holdings make up 21% of its $178B portfolio in Q3 2022.
- UBS AM opened 65 new positions and closed 77 in Q3 2022.
- UBS AM's portfolio value fell 6.6% quarter-over-quarter to $178B.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.